Burman K D
Washington Hospital Center, Washington, D.C., USA.
Hosp Pract (1995). 1997 Dec 15;32(12):71-3, 78-85; discussion 85-6. doi: 10.1080/21548331.1997.11443608.
Prolonged elevation of thyroid hormones has been linked to osteoporosis and increased fracture risk. Whether thyroid hormone suppression also increases those risks remains controversial. Prophylaxis is often appropriate for patients who have had thyroid disorders, with assessment of bone mineral density and perhaps pharmacologic therapy for those with additional risk factors.
甲状腺激素长期升高与骨质疏松症及骨折风险增加有关。甲状腺激素抑制是否也会增加这些风险仍存在争议。对于患有甲状腺疾病的患者,预防性措施通常是合适的,需评估骨密度,对于有其他风险因素的患者可能需要药物治疗。